Updated Adjuvant Chemotherapy for Gastric Cancer
Surgical resection is currently the best curative approach for gastric cancer (GC); however, the prognosis of patients with advanced GC remains poor even with curative resection. For this reason, perioperative chemotherapy has been combined with surgery to reduce the risk of postoperative recurrence...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-10-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/21/6727 |
| _version_ | 1797631743313838080 |
|---|---|
| author | Toshizo Takayama Yasushi Tsuji |
| author_facet | Toshizo Takayama Yasushi Tsuji |
| author_sort | Toshizo Takayama |
| collection | DOAJ |
| description | Surgical resection is currently the best curative approach for gastric cancer (GC); however, the prognosis of patients with advanced GC remains poor even with curative resection. For this reason, perioperative chemotherapy has been combined with surgery to reduce the risk of postoperative recurrence. Standard perioperative chemotherapy for resectable advanced GC varies from region to region. Postoperative S-1 therapy was standardized via the ACTS-GC study in East Asia, perioperative ECF (Epirubicin + Cisplatin + Fluorouracil) was standardized via the MAGIC study in Europe, and postoperative chemoradiotherapy was standardized via the US intergroup study in North America. Since then, more intensive regimens have been developed. In recent years, perioperative therapy using novel agents, such as molecular-targeted drugs and immune checkpoint inhibitors (ICIs), has also been tested and evaluated in the three major regions (East Asia, Europe, and North America) with promising results. Perioperative chemotherapy has become an integral part of many treatment strategies and requires continued research and evaluation. |
| first_indexed | 2024-03-11T11:27:41Z |
| format | Article |
| id | doaj.art-b2b9c8adf8ff4602a26b8d668e96845e |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-11T11:27:41Z |
| publishDate | 2023-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-b2b9c8adf8ff4602a26b8d668e96845e2023-11-10T15:06:14ZengMDPI AGJournal of Clinical Medicine2077-03832023-10-011221672710.3390/jcm12216727Updated Adjuvant Chemotherapy for Gastric CancerToshizo Takayama0Yasushi Tsuji1Department of Medical Oncology, Tonan Hospital, Sapporo 060-0004, JapanDepartment of Medical Oncology, Tonan Hospital, Sapporo 060-0004, JapanSurgical resection is currently the best curative approach for gastric cancer (GC); however, the prognosis of patients with advanced GC remains poor even with curative resection. For this reason, perioperative chemotherapy has been combined with surgery to reduce the risk of postoperative recurrence. Standard perioperative chemotherapy for resectable advanced GC varies from region to region. Postoperative S-1 therapy was standardized via the ACTS-GC study in East Asia, perioperative ECF (Epirubicin + Cisplatin + Fluorouracil) was standardized via the MAGIC study in Europe, and postoperative chemoradiotherapy was standardized via the US intergroup study in North America. Since then, more intensive regimens have been developed. In recent years, perioperative therapy using novel agents, such as molecular-targeted drugs and immune checkpoint inhibitors (ICIs), has also been tested and evaluated in the three major regions (East Asia, Europe, and North America) with promising results. Perioperative chemotherapy has become an integral part of many treatment strategies and requires continued research and evaluation.https://www.mdpi.com/2077-0383/12/21/6727adjuvant chemotherapyperioperative treatmentgastric cancer |
| spellingShingle | Toshizo Takayama Yasushi Tsuji Updated Adjuvant Chemotherapy for Gastric Cancer Journal of Clinical Medicine adjuvant chemotherapy perioperative treatment gastric cancer |
| title | Updated Adjuvant Chemotherapy for Gastric Cancer |
| title_full | Updated Adjuvant Chemotherapy for Gastric Cancer |
| title_fullStr | Updated Adjuvant Chemotherapy for Gastric Cancer |
| title_full_unstemmed | Updated Adjuvant Chemotherapy for Gastric Cancer |
| title_short | Updated Adjuvant Chemotherapy for Gastric Cancer |
| title_sort | updated adjuvant chemotherapy for gastric cancer |
| topic | adjuvant chemotherapy perioperative treatment gastric cancer |
| url | https://www.mdpi.com/2077-0383/12/21/6727 |
| work_keys_str_mv | AT toshizotakayama updatedadjuvantchemotherapyforgastriccancer AT yasushitsuji updatedadjuvantchemotherapyforgastriccancer |